Search Results

The Tisch MS Research Center of New York, the world’s largest MS research center, has announced publication of the results of its FDA-approved Phase II stem cell treatment study in a leading stem cell journal, Stem Cell Research & Therapy.

The Tisch Multiple Sclerosis Research Center of New York, the world’s largest independent research center focusing on MS, is proud to announce that its FDA-approved stem cell treatment study was featured in an article in BioSpace.

Valent BioSciences celebrated the grand opening of the new Venburg Wing at the company’s Melnik and Shafer Biorational Research Center in Libertyville, Illinois, during a special ceremony.

Committed to advancing gastrointestinal research, Lynx.MD, the industry-leading medical data intelligence platform tailored specifically for the gastroenterology market, announces its collaboration with New York Gastroenterology Associates.

Anteris Technologies Ltd announced a summation of the Company’s presentation at the New York Valves annual Conference held at the Jacob K. Javits Convention Center in New York City.

In a significant advancement for cancer research and treatment, Astrin Biosciences, a leader in AI-empowered 3D holographic technology for cancer cell detection, has announced a comprehensive research collaboration with Memorial Sloan Kettering Cancer Center.

Children’s Hospital of Philadelphia announced that it has received a significant philanthropic gift from Mitchell L. Morgan, Dr. Hilarie L. Morgan and their family to name its state-of-the-art research facility currently under construction on the South Street bridge next to CHOP’s Roberts Center for Pediatric Research.

AbTherx, Inc., a biotechnology company with innovative technologies that enable and accelerate antibody discovery, announced the opening of its new antibody discovery technologies research center.

NTT Research, Inc., a division of NTT, announced that the NTT Research Foundation, a 5013 organization, has made a gift to establish the Harvard University Center for Brain Science -NTT Fellowship Program in the new field of Physics of Intelligence.

Anteris Technologies Ltd, a structural heart company developing DurAVR™ THV, a new class of TAVR and the world’s only balloon-expandable, single-piece biomimetic aortic replacement valve shaped to mimic the native human valve, announced a summation of the Company’s presentation at the New York Valves annual Conference held at the Jacob K. Javits Convention Center in New York City.